Article
FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men.
Prostate cancer and prostatic diseases - 1 Mar 2010
Ho C K M, Anwar S, Nanda J, Habib F K
Abstract excerpt
Fibroblast growth factor receptor 4 (FGFR4), a member of the fibroblast growth receptor family, was recently reported to be more abundantly expressed in malignant than benign prostate cells. A single nucleotide polymorphism at position 388 of the FGFR4 amino-acid sequence results in the substitution of glycine (Gly) with arginine (Arg) and higher frequency of the ArgArg genotype was previously found in prostate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
